PubRank

Monica Airoldi

Author PubWeight™ 15.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis 2004 3.95
2 Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials 2007 2.43
3 Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 2002 1.18
4 Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS 2007 0.99
5 CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One 2010 0.96
6 CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART. AIDS 2009 0.93
7 Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy. J Clin Lab Anal 2002 0.86
8 Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort. J Antimicrob Chemother 2007 0.86
9 Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. Antivir Ther 2010 0.84
10 Back to the ring: knocking-out headache. Neurol Sci 2011 0.83
11 Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance. J Int Assoc Physicians AIDS Care (Chic) 2007 0.80
12 Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohort. HIV Clin Trials 2007 0.77
13 Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV. HIV Clin Trials 2002 0.76
14 Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: relapse or late IRIS? J Antimicrob Chemother 2011 0.75